Davis's Drug Guide
brexucabtagene autoleucel
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
brex-ue-kab-ta-jeen aw-toe-loo-sel
Trade Name(s)
- Tecartus
Ther. Class.
Pharm. Class.
CAR-T cell immunotherapies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Brexucabtagene Autoleucel." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580163/all/brexucabtagene_autoleucel.
Vallerand AHA, Sanoski CAC. Brexucabtagene autoleucel. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580163/all/brexucabtagene_autoleucel. Accessed August 4, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Brexucabtagene autoleucel. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580163/all/brexucabtagene_autoleucel
Vallerand AHA, Sanoski CAC. Brexucabtagene Autoleucel [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 04]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580163/all/brexucabtagene_autoleucel.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - brexucabtagene autoleucel
ID - 3580163
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580163/all/brexucabtagene_autoleucel
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -
